Cargando…

The overall benefits of empagliflozin treatment in adult siblings with glycogen storage disease type Ib: one year experience

INTRODUCTION: Recently published case reports suggest the benefit of empagliflozin use in subjects with glycogen storage disease Ib (GSD Ib). METHODS: We present the clinical and laboratory data of 2 adult brothers with GSD Ib treated with empagliflozin for 12 months. RESULTS: There was no severe in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bidiuk, Joanna, Gaciong, Zbigniew A., Sobieraj, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266796/ https://www.ncbi.nlm.nih.gov/pubmed/35982912 http://dx.doi.org/10.5114/aoms/150029

Ejemplares similares

Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment
por: Tallis, Eran, et al.
Publicado: (2022)

Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
por: Grünert, Sarah Catharina, et al.
Publicado: (2022)

Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study
por: Grünert, Sarah C., et al.
Publicado: (2023)

Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib
por: Grünert, Sarah C., et al.
Publicado: (2020)

Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report
por: Makrilakis, Konstantinos, et al.
Publicado: (2022)

Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
por: Rossi, Alessandro, et al.
Publicado: (2021)

Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report
por: Calia, Margherita, et al.
Publicado: (2023)

Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre
por: Halligan, Rebecca K., et al.
Publicado: (2022)

Low on-treatment diastolic blood pressure and cardiovascular outcome: A post-hoc analysis using NHLBI SPRINT Research Materials
por: Sobieraj, Piotr, et al.
Publicado: (2019)

The natural history of glycogen storage disease type Ib in England: A multisite survey
por: Halligan, Rebecca, et al.
Publicado: (2021)

Glycogen Storage Disease Ib and Severe Periodontal Destruction: A Case Report
por: Ma, Rui, et al.
Publicado: (2018)

Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders
por: Maiorana, Arianna, et al.
Publicado: (2023)

Low Diastolic Blood Pressure is Not Related to Risk of First Episode of Stroke in a High‐Risk Population: A Secondary Analysis of SPRINT
por: Sobieraj, Piotr, et al.
Publicado: (2019)

Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors
por: Murko, Simona, et al.
Publicado: (2023)

Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients
por: Hexner-Erlichman, Zufit, et al.
Publicado: (2022)

Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib
por: Choi, Rihwa, et al.
Publicado: (2017)

Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort
por: Wicker, Camille, et al.
Publicado: (2020)

Mutation analysis of SLC37A4 in a patient with glycogen storage disease-type Ib
por: Zhang, Yamei, et al.
Publicado: (2019)

Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib
por: Du, Caiqi, et al.
Publicado: (2021)

A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia
por: Wang, Fengyu, et al.
Publicado: (2021)

Clinical Remission of Severe Crohn’s Disease with Empagliflozin Monotherapy in a Pediatric Patient with Glycogen Storage Disease Type 1b
por: Collen, Lauren V., et al.
Publicado: (2023)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

Finding balance between mature and immature neutrophils: The effects of empagliflozin in GSD‐Ib
por: Guerra, Fabiola, et al.
Publicado: (2023)

Hepatic glycogen storage diseases: pathogenesis, clinical symptoms and therapeutic management
por: Szymańska, Edyta, et al.
Publicado: (2019)

Glycogen storage diseases: An update
por: Gümüş, Ersin, et al.
Publicado: (2023)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

Biomarkers in Glycogen Storage Diseases: An Update
por: Molares-Vila, Alberto, et al.
Publicado: (2021)

ON THE DIFFERING APPEARANCE OF INTRANUCLEAR AND CYTOPLASMIC GLYCOGEN IN LIVER CELLS IN GLYCOGEN STORAGE DISEASE
por: Sheldon, H., et al.
Publicado: (1962)

One Small Step for Empagliflozin, One Giant Leap for Diabetology
por: Kalra, Sanjay
Publicado: (2015)

Determining mutations in G6PC and SLC37A4 genes in a sample of Brazilian patients with glycogen storage disease types Ia and Ib
por: Carlin, Marcelo Paschoalete, et al.
Publicado: (2013)

Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway
por: Yu, Xiaochen, et al.
Publicado: (2022)

Performance of 24-hour urinary creatinine excretion-estimating equations in relation to measured 24-hour urinary creatinine excretion in hospitalized hypertensive patients
por: Jędrusik, Piotr, et al.
Publicado: (2019)

Glycogen storage disease presenting as Cushing syndrome
por: Stefater, Margaret A., et al.
Publicado: (2019)

Neurological Characteristics of Pediatric Glycogen Storage Disease
por: Muzetti, Julio Henrique, et al.
Publicado: (2021)

Over 20-Year Follow-up of Patients with Hepatic Glycogen Storage Diseases: Single-Center Experience
por: Szymańska, Edyta, et al.
Publicado: (2020)

Different diagnostic criteria significantly affect the rates of hypertension in 18-year-old high school students
por: Symonides, Bartosz, et al.
Publicado: (2010)

Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using (13)C-glucose breath test
por: Turki, Abrar, et al.
Publicado: (2023)

Liver transplantation in glycogen storage disease: a single-center experience
por: Beyzaei, Zahra, et al.
Publicado: (2022)

Preference and Adherence to a Fixed-Dose Combination of Bisoprolol–Aspirin and Blood Pressure Control: Results of an Open-Label, Multicentre Study
por: Gaciong, Zbigniew
Publicado: (2022)

New Insights into the Use of Empagliflozin—A Comprehensive Review
por: Forycka, Joanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rcm50lieoceh8l75h86tlkh2es